Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
NEW HAVEN, Conn., Aug. 29, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Dan Wechsler, President and CEO of Melinta, will present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York, NY. The presentation will take place on Weds., Sept. 5 at 12:05 p.m. Eastern Time.
A live and archived webcast of the presentation will be accessible from Melinta’s Investor Relations website at http://ir.melinta.com/. The webcast can also be accessed from the following URL: http://wsw.com/webcast/rrshq28/mlnt/.